Latest Funding And Finance News

Papyrus Australia reported a $112k net operating cash outflow in October 2025, offset by financing activities and R&D tax incentives, maintaining a runway of over five months. Despite a non-recurring legal expense and an investment write-down, the company remains confident in its operational continuity.

VHM Limited has launched a non-underwritten Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to invest up to $30,000 at $0.35 per share, a significant discount to recent trading prices. The capital raised will support key development stages of the Goschen Project ahead of a final investment decision in early 2026.

Critica Limited has raised A$8 million in an oversubscribed placement to accelerate development of its Jupiter rare earths project, positioning itself as a key supplier of critical minerals for emerging technologies.

Diablo Resources reported a modest operating cash outflow and significant exploration spending in the September quarter, offset by a recent $2 million capital raise to support ongoing activities.

Southern Palladium has cleared major regulatory hurdles and confirmed robust economics for its Bengwenyama platinum group metals project, supported by a $20 million capital raise to fund next-stage development.

Challenger Gold has raised A$30 million through an institutional placement to fund the ramp-up of its Hualilan gold project and support an extensive drilling campaign ahead of first production in early 2026.

Latrobe Magnesium Limited has received a non-binding Letter of Interest from the U.S. Export Import Bank to finance up to A$200 million for its Stage 2 Commercial Magnesium Plant, aiming to strengthen critical mineral supply chains for the U.S.

Pinnacle Minerals has secured a strategic acquisition of eight critical minerals projects in Idaho and Washington, positioning itself at the forefront of the US critical minerals supply chain. The company also raised $3 million to accelerate exploration and development.

Ardiden Ltd’s trading suspension has been lifted following its announcement of a significant gold acquisition and a capital raising initiative, signaling a pivotal moment for the company’s growth strategy.

Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent, progressing toward a Phase 2 clinical trial with strong collaborations and a recent AU$3.5 million capital raise.

Caspin Resources has successfully raised $4.5 million through a heavily oversubscribed equity placement, positioning the company to advance drilling at its Weethalle Gold and Bygoo Tin projects in New South Wales.

archTIS Limited has opened the retail component of a $17 million entitlement offer to support its acquisition of Spirion LLC’s assets, aiming to expand its US footprint and enhance its cybersecurity product suite.